[go: up one dir, main page]

JPS61271234A - Vinyl fluoride derivative and production thereof - Google Patents

Vinyl fluoride derivative and production thereof

Info

Publication number
JPS61271234A
JPS61271234A JP11137885A JP11137885A JPS61271234A JP S61271234 A JPS61271234 A JP S61271234A JP 11137885 A JP11137885 A JP 11137885A JP 11137885 A JP11137885 A JP 11137885A JP S61271234 A JPS61271234 A JP S61271234A
Authority
JP
Japan
Prior art keywords
group
formula
vinyl fluoride
compound
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11137885A
Other languages
Japanese (ja)
Inventor
Yoshiro Kobayashi
小林 義郎
Takeo Taguchi
武夫 田口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Priority to JP11137885A priority Critical patent/JPS61271234A/en
Publication of JPS61271234A publication Critical patent/JPS61271234A/en
Pending legal-status Critical Current

Links

Landscapes

  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:A vinyl fluoride derivative shown by the formula I [A is group shown by the formula II (R<1> is alkylene), formula III, etc.; B is group shown by the formula IV (R<2> is monohydric alcohol residue or H; m is 0-5) or group shown by the formula V(X is OH, halogen or nitrile; n is 1-5)]. EXAMPLE:Ethyl 5,6-dihydroxy-2-fluoro-2-hexenoate 5,6-acetonide(3). USE:An intermediate for a fluorine-containing physiologically active substance. PREPARATION:An aldehyde shown by the formula VI is reacted with Wittig reaction shown by the formula VII (R<4> is alkyl, aryl, or aralkyl), and, if necessary, further reduced, and halogenated and/or subjected to carbon increasing reaction to give a vinyl fluoride derivative shown by the formula I.

Description

【発明の詳細な説明】 本発明は新規なビニルフルオリド誘導体およびその製造
法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel vinyl fluoride derivative and a method for producing the same.

生理活性物質の開発分野において、末端にカルボキシル
基やその誘導体基(エステル基など)を有する長鎖アル
キル化合物はカルボキシル基を有する生理活性物質の中
間体として有用である。たとえば、プロスタグランジン
、プロスタサイクリン、トロンボキサン、ロイコトリエ
フ。アラキドン酸、その他の末端にカルボキシル基を有
する長鎖炭化水素基をその構成に含む生理活性物質の中
間体として有用である。一方、生理活性物質あるいはそ
の類似化合物にフッ素原子を導入した化合物は、そのフ
ッ素原子による新たな生理活性が期待される故に種々の
検討対象となっている。このようなフッ素原子含有生理
活性物質を合成するに当っては、フッ素原子を含む上記
のような中間体を必要とする場合が少なくない。このフ
ッ素原子含有中間体として比較的単純なビニルフルオリ
ド類は数多く知られている(たとえば、[有機合成化学
協会誌」第42巻、第770頁〜808頁、 1984
年)。
In the field of developing physiologically active substances, long-chain alkyl compounds having a carboxyl group or a derivative group thereof (such as an ester group) at the end are useful as intermediates for physiologically active substances having a carboxyl group. For example, prostaglandins, prostacyclin, thromboxane, leukotrief. It is useful as an intermediate for arachidonic acid and other physiologically active substances whose structure includes a long-chain hydrocarbon group having a carboxyl group at the end. On the other hand, compounds in which fluorine atoms are introduced into physiologically active substances or similar compounds thereof are the subject of various studies because new physiological activities due to the fluorine atoms are expected. In synthesizing such fluorine atom-containing physiologically active substances, the above-mentioned intermediates containing fluorine atoms are often required. Many relatively simple vinyl fluorides are known as these fluorine atom-containing intermediates (for example, Journal of the Society of Organic Synthetic Chemistry, Vol. 42, pp. 770-808, 1984).
Year).

しかしながら、比較的長い炭化水素鎖を有するビニルフ
ルオリド類はあまり知られていない。
However, vinyl fluorides with relatively long hydrocarbon chains are not well known.

本発明は前記のような含フツ素生理活性物質の中間体と
して有用な新規なビニルフルオリド誘導体とその製造法
を提供するものであり、以下の2つの発明である。
The present invention provides a novel vinyl fluoride derivative useful as an intermediate for the above-mentioned fluorine-containing physiologically active substances and a method for producing the same, and consists of the following two inventions.

下記式(I)で表されるビニルフルオリド誘導体。A vinyl fluoride derivative represented by the following formula (I).

(ただし、R1は全体として5〜6員環を形成する炭素
数1〜5のアルキレン基)B : +CIh ) ac
OOR’ 、 アロ イは4GH2′+nXただし R
2は1価アルコールの残基、あるいは水素原子。
(However, R1 is an alkylene group having 1 to 5 carbon atoms that forms a 5 to 6-membered ring as a whole) B: +CIh) ac
OOR', alloy is 4GH2'+nX but R
2 is a monohydric alcohol residue or a hydrogen atom.

Xは水酸基、ハロゲン原子、あ るいはニトリル基 mはO〜5の整数 nは1〜5の整数 下記式(II)で表されるアルデヒド類と下記式(II
I)で表されるウィッチヒ試薬を反応させ、必要に応じ
てさらに還元、ハロゲン化、および/または増炭反応を
行なうことを特徴とする上記式(I)で表されるビニル
フルオリド誘導体の製造法。
X is a hydroxyl group, a halogen atom, or a nitrile group m is an integer of O to 5 n is an integer of 1 to 5 Aldehydes represented by the following formula (II) and the following formula (II
Production of a vinyl fluoride derivative represented by the above formula (I), which is characterized by reacting the Witsch reagent represented by I) and further performing reduction, halogenation, and/or carbonization reactions as necessary. Law.

(II)        (III) ただし、R4:アルキル基、アリール基。(II) (III) However, R4: alkyl group, aryl group.

あるいはアルアルキル基 B:上記に同じ 上記本発明ビニルフルオリド誘導体としては、最終的に
はAがアルデヒド基である化合物が有用である。しかし
、種々の生理活性物質の中間体として有用なAがアルデ
ヒド基である化合物を合成する段階では、Aがアルデヒ
ド基であるとそのアルデヒド基が反応に関与するおそれ
があり、従ってその場合はAはアルデヒド基に変換しう
る前記のような基であることが好ましい、即ち、Aが酸
素原子含有5〜6員環あるいはジヒドロキシエチル基で
ある化合物はAがアルデヒド基である化合物の合成中間
体として有用である。Aがアルデヒド基である化合物は
、たとえば前記以外のウィッチヒ試薬、特に長鎖炭化水
素基や環状炭化水素基を有するライ・ノチヒ試薬と反応
させて目的とするフッ素原子含有生理活性物質や新たな
その合成中間体の合成に利用される。なお、R1として
は全体として酸素原子を含む5〜6員環(即ち1.3ジ
オキソラン環や1.4〜ジオギサン環〕を形成する分岐
状あるいは直鎖状のフルキレン基やアルキリデン基であ
り、特にメチレン基、エチレン基、プロピレン基、エチ
リデン基、インプロピリデン基などが適当で特にインプ
ロピリデン基とメチレン基が好ましい。
Alternatively, aralkyl group B: As the above-mentioned vinyl fluoride derivative of the present invention, a compound in which A is an aldehyde group is ultimately useful. However, in the step of synthesizing compounds in which A is an aldehyde group, which are useful as intermediates for various physiologically active substances, if A is an aldehyde group, the aldehyde group may be involved in the reaction; is preferably a group as described above that can be converted into an aldehyde group, that is, a compound in which A is an oxygen atom-containing 5- to 6-membered ring or a dihydroxyethyl group can be used as a synthetic intermediate for a compound in which A is an aldehyde group. Useful. Compounds in which A is an aldehyde group can be reacted, for example, with Witsch reagents other than those mentioned above, especially Rei-Nochig reagents having long-chain hydrocarbon groups or cyclic hydrocarbon groups, to produce desired fluorine-containing physiologically active substances or new substances. Used in the synthesis of synthetic intermediates. In addition, R1 is a branched or linear fullkylene group or alkylidene group that forms a 5- to 6-membered ring containing an oxygen atom (i.e., a 1.3-dioxolane ring or a 1.4-diogythane ring), and especially Suitable groups include methylene group, ethylene group, propylene group, ethylidene group, and impropylidene group, with impropylidene group and methylene group being particularly preferred.

Bは末端に特定の官能基を有する直鎖状アルキル基また
は直鎖状アルキル基を有しないカルポキシ基などである
。含フツ素生理活性物質の中間体として特に有用な本発
明のビニルフルオリド誘導体はBが4GH2) 500
0R?で表される基であるものである。 R2は水素原
子であってもよいが通常はエステルを形成する1価アル
コールの残基が好ましく、特に炭素数1−10の炭化水
素基が適当である。特にアルキル基が好ましいが、アル
ケニル基やアルアルキル基などであってもよい、最も好
ましくは炭素数1〜6のアルキル基である6mは上記の
ようにOであってもよく、特に2あるいは3が好ましい
、Bが4CH2f nXで表される基である化合物は上
記Bが4CH2) ncOOR’で表される基である化
合物の合成中間体として有用である。しかし、これに限
られるものではなく、特にXが水酸基である化合物は、
本発明の目的とする中間体として用いることもできる。
B is a linear alkyl group having a specific functional group at its terminal or a carpoxy group having no linear alkyl group. The vinyl fluoride derivative of the present invention, which is particularly useful as an intermediate for fluorine-containing physiologically active substances, has B of 4GH2) 500
0R? It is a group represented by Although R2 may be a hydrogen atom, it is usually a residue of a monohydric alcohol that forms an ester, and a hydrocarbon group having 1 to 10 carbon atoms is particularly suitable. In particular, an alkyl group is preferred, but it may also be an alkenyl group or an aralkyl group, and 6m, which is most preferably an alkyl group having 1 to 6 carbon atoms, may be O as described above, especially 2 or 3 A compound in which B is preferably a group represented by 4CH2f nX is useful as a synthetic intermediate for a compound in which B is a group represented by 4CH2) ncOOR'. However, it is not limited to this, and in particular, compounds where X is a hydroxyl group,
It can also be used as an intermediate for the purposes of the present invention.

nは特に1〜3の整数であるこが好ましい、ハロゲンと
しては塩素原子。
In particular, n is preferably an integer of 1 to 3, and the halogen is a chlorine atom.

臭素原子、ヨウ素原子が好ましく、特に臭素原子とヨウ
素原子が適当である。
A bromine atom or an iodine atom is preferred, and a bromine atom and an iodine atom are particularly suitable.

本発明の前記ビニルフルオリド誘導体は前記式(n)で
表されるアルデヒド類と前記式(III)で表されるウ
ィッチヒ試薬を反応させることによって得られる。一般
的なウィッチヒ試薬の製造法やそれを使用した反応方法
は公知であり。
The vinyl fluoride derivative of the present invention can be obtained by reacting the aldehyde represented by the formula (n) with the Witsch reagent represented by the formula (III). General methods for producing Witsch reagents and reaction methods using them are well known.

たとえばrchem、Lett、1978.1001 
JやrJ、Med。
For example, rchem, Lett, 1978.1001
J and rJ, Med.

Chew、 23,1077(IHO) Jなどの文献
に記載されている。この公知の製造法によって式(II
I)で表されるウィッチヒ試薬を得ることができ、また
公知の反応方法に準拠して上記アルデヒド類とこのウィ
ッチ試薬を反応させることができる。前記式(III)
で表されるウィッチヒ試薬としてはBが4 CH2) 
a COOR2である化合物、特にそのmが0である一
GOOR2が好ましい、R4としては、炭素数1〜10
のアルキル基、または置換基を有していてもよいフェニ
ル基あるいはベンジル基が好ましく、特に炭素数1〜4
のアルキル基が好ましい。
Chew, 23, 1077 (IHO) J. By this known production method, the formula (II)
The Witsch reagent represented by I) can be obtained, and the above-mentioned aldehydes and this Witsch reagent can be reacted according to known reaction methods. The above formula (III)
B is 4 CH2) as the Witsch reagent represented by
a Compounds that are COOR2, particularly GOOR2 whose m is 0, are preferred; R4 has 1 to 10 carbon atoms;
An alkyl group, or a phenyl group or benzyl group which may have a substituent is preferable, and in particular an alkyl group having 1 to 4 carbon atoms.
The alkyl group is preferred.

上記式(■)で表されるアルデヒド類と式(III)で
表されるウィッチ試薬を反応させて得られる化合物は前
記式(I)で表されるビニルフルオリド誘導体の化合物
群の一部が得られる。さらに、必要によりこの得られた
化1合物を還元、ハロゲン化、増炭反応(炭素鋼を延長
する反応)を行なうことにより他のビニルフルオリド誘
導体が得られる。特に、(([2矢書COOR2なるB
の基のmを増加させる増炭反応が行なわれ1mがOであ
る化合物からmが2あるいは3に増加させる増炭反応が
採用される。この増炭反応のために、多くの場合Bが(
CTo ) nXである化合物が使用される。即ちBが
(CH2) nXである化合物を経由して4CH2) 
acOOR’な、るBのmの数が増加した化合物が得ら
れる。
The compound obtained by reacting the aldehyde represented by the above formula (■) with the Witch reagent represented by the formula (III) contains a part of the vinyl fluoride derivative compound group represented by the above formula (I). can get. Further, if necessary, other vinyl fluoride derivatives can be obtained by subjecting the obtained compound 1 to reduction, halogenation, and carburization reaction (reaction to extend carbon steel). In particular, (([2 arrow COOR2 becomes B
A carburization reaction is carried out to increase the m of the group, and a carburization reaction is employed to increase m to 2 or 3 from a compound where 1m is O. Because of this carburization reaction, B is often (
Compounds that are CTo ) nX are used. i.e. 4CH2) via a compound where B is (CH2) nX
A compound in which the number of m in B, which is acOOR', is increased is obtained.

後述実施例における反応および化合物のフローチャート
は以下の通りである(略号は実施例参照)。
Flowcharts of reactions and compounds in the Examples described below are as follows (see Examples for abbreviations).

(l)                      
           【3)」;配化合物(I)は前
記式(IT)で表される化合物の一例であり、化合物(
2)は前記式(III)で表される化合物の一例である
。化合物(3)。
(l)
Compound (I) is an example of a compound represented by the above formula (IT), and compound (I) is an example of a compound represented by the above formula (IT).
2) is an example of the compound represented by the above formula (III). Compound (3).

(4)、(5)、(7)、(8)、(I0)、(I1)
、(I2)および(I3)は前記式(I)で表される本
発明のビニルフルオリド誘導体の例である。前記のよう
に、本発明において好ましい化合物はAがアルデヒド基
でありBが(CH2)□GOOR2である化合物であり
、上記例では化合物(I3)である。この化合物はAが
アルデヒド基に変換される前の化合物、たとえば化合物
(I1)より合成される。化合物(I1)よりもnの数
が小さい以外は全く同一構造(R2を除く)を有する化
合物(3)および(7)は化合物(!1)から化合物(
I3)を合成する方法とほとんど同一の合成方法により
nの数が小さい以外は化合物(I3)と全く同一構造(
R2を除く)のアルデヒド基を有する化合物が得られる
。このnの数の小さいアルデヒド基を有する化合物も化
合物(I3)と同様に有用な中間体である。
(4), (5), (7), (8), (I0), (I1)
, (I2) and (I3) are examples of the vinyl fluoride derivative of the present invention represented by the above formula (I). As mentioned above, a preferred compound in the present invention is a compound in which A is an aldehyde group and B is (CH2)□GOOR2, which is compound (I3) in the above example. This compound is synthesized from a compound before A is converted into an aldehyde group, such as compound (I1). Compounds (3) and (7), which have exactly the same structure (excluding R2) except that the number of n is smaller than compound (I1), can be synthesized from compound (!1) to compound (
Compound (I3) has exactly the same structure as compound (I3) except that the number of n is small, using almost the same synthesis method as that of
A compound having an aldehyde group (excluding R2) is obtained. Compounds having aldehyde groups with a small number of n are also useful intermediates like compound (I3).

後述参考例として(I3)より5−フルオロアラキドン
酸エステルを合成する例を示す。アラキドン酸はそれ自
身生理活性を有するとともに生体中におけるプロスタグ
ランジ、ロイコトリエン、トロンボキサン等の出発物質
として極めて重要な化合物である。従って、5−フルオ
ロアラキドン酸はプロスタグランジ等の生合成阻害剤や
アンタゴニストして有用であると考えられる化合物であ
る。
An example of synthesizing 5-fluoroarachidonic acid ester from (I3) will be shown as a reference example to be described later. Arachidonic acid itself has physiological activity and is an extremely important compound as a starting material for prostagrangees, leukotrienes, thromboxanes, etc. in living organisms. Therefore, 5-fluoroarachidonic acid is a compound considered to be useful as a biosynthesis inhibitor or antagonist of prostagranges and the like.

以下実施例により本発明を具体的に説明するが、本発明
はこれら実施例に限られるものではない。
EXAMPLES The present invention will be specifically explained below with reference to Examples, but the present invention is not limited to these Examples.

実施例 アルゴン気流下、−78℃(ドライアイス−アセトン浴
)でジインプロピルアミン(3,3mQ、30mmol
)のエーテル溶液にn−BuLi(I,4%−ヘキサン
溶液24゜5gmol)を加えて20分間攪拌後、ジエ
チルホスホノフルオロ酢酸エチル(2) (8,5g、
35mmol)を加え、−78℃で5分間、0℃で20
分間攪拌する。反応液を一78℃に冷却後、3.4−ジ
ヒドロキシブタナル 3.4−アセトニド(I)(5,
1g、35+u+ol)のエーテル溶液(5sl)を加
えて、−78℃で2時間攪拌後、食塩水を加えてエーテ
ルで抽出する。エーテル抽出液を水洗、乾D!(MgS
Oa)後、減圧上濃縮し、残渣をシリカゲルカラムクロ
マトグラフィーで分離精製し、n−へキサン酢酸エチル
(5:1)溶出部分より、(3)をEi、88g(収率
85%)を得た。
Example Diynpropylamine (3.3 mQ, 30 mmol
) was added n-BuLi (I, 4% hexane solution 24°5 gmol) and stirred for 20 minutes, followed by ethyl diethylphosphonofluoroacetate (2) (8.5g,
35 mmol) and incubated at -78°C for 5 minutes and at 0°C for 20 minutes.
Stir for a minute. After cooling the reaction solution to -78°C, 3,4-dihydroxybutanal 3,4-acetonide (I) (5,
An ether solution (5 sl) of 1 g, 35+u+ol) was added thereto, and after stirring at -78°C for 2 hours, brine was added and extracted with ether. Wash the ether extract with water and dry it! (MgS
After Oa), it was concentrated under reduced pressure, and the residue was separated and purified by silica gel column chromatography, and 88 g (yield 85%) of (3) was obtained from the fraction eluted with n-hexane ethyl acetate (5:1). Ta.

(3):bp 115〜120℃/3a+mHg; I
H−NMR(CD、Cl5)6.00(IH,dt、J
=  21and7.5)1z)”。
(3): bp 115-120℃/3a+mHg; I
H-NMR (CD, Cl5) 6.00 (IH, dt, J
= 21and7.5)1z)”.

19F−NMR(CDC:13) 55、lppm (d、J=21Hz)◆喫、129゜
MS” (+oHzF+04[217,0B74121
7.0849拳テトラメチルシランを内部標準に用いた
19F-NMR (CDC: 13) 55, lppm (d, J=21Hz)
7.0849 tetramethylsilane was used as an internal standard.

赤拳ベンゾトリフルオリドを内部標準に用いた”” M
S:マススペクトル、[]内計算値アルゴン気流下(3
) (8,88g、29.85mmol)のエーテル溶
液(30腫1)にづ8℃でジインブチルアルミニウムヒ
ドリド(DIBAL−H) (0,7Mヘキサン溶液4
21)を加え、30分間攪拌する。反応液に食塩水を加
え、セライトを用いてろ過し、ろ液をエーテルで2回抽
出して、Hg5Oaで乾燥後、減圧下?M縮する。残渣
をシリカゲルカラムクロマトグラフ4−で精製(hex
ane:Ac0Et*l:1) L/ 、 (4)を5
.1g (収率80%)得る。
"" M using Red Fist benzotrifluoride as internal standard
S: Mass spectrum, calculated values in [ ] under argon flow (3
) (8.88 g, 29.85 mmol) at 8° C. in an ether solution (30 mmol) (0.7 M hexane solution 4).
Add 21) and stir for 30 minutes. Brine was added to the reaction solution, filtered through Celite, the filtrate was extracted twice with ether, dried over Hg5Oa, and then extracted under reduced pressure. M shrinks. The residue was purified by silica gel column chromatography (hex
ane:Ac0Et*l:1) L/, (4) to 5
.. 1 g (80% yield) is obtained.

(4):IH−NMR(CDCh)  5.19(I)
l、dt、J−21and7.5 Hz、−CH=CF
−) IR: 3400 cm−1 MS  CsH+zF、+03[175,07f391
175.0761アルゴン気流下、あらかじめよく乾燥
したLiBr(f(g、57.2a+mol)にTHF
溶液(30ml)を加え、−78℃まで冷却し、(4)
(3℃g、18.9mmol)を加え、5分間攪拌後、
n−BuLi(I,4M、13.3sl、 19+mo
l)を加え、30分間攪拌する。さらに塩化メタンスル
ホニル −78℃で30分間攪拌し,徐々−に室温まで反応温度
を上げ、2時間攪拌する.反応液に食塩水を加え,エー
テルで2回抽出し、有機層を2回水洗する.有機層をM
gSOnで乾燥後減圧下濃縮し、(5) It 4.5
5g  (収率95.15K)得る。
(4): IH-NMR (CDCh) 5.19 (I)
l, dt, J-21and7.5 Hz, -CH=CF
-) IR: 3400 cm-1 MS CsH+zF, +03[175,07f391
175.0761 Under a stream of argon, THF was added to LiBr (f (g, 57.2a + mol), which had been thoroughly dried in advance).
Add the solution (30 ml) and cool to -78°C, (4)
(3℃g, 18.9mmol) was added, and after stirring for 5 minutes,
n-BuLi (I, 4M, 13.3sl, 19+mo
Add l) and stir for 30 minutes. The methanesulfonyl chloride mixture was further stirred at -78°C for 30 minutes, the reaction temperature was gradually raised to room temperature, and the mixture was stirred for 2 hours. Add brine to the reaction solution, extract twice with ether, and wash the organic layer twice with water. Organic layer M
After drying with gSOn and concentrating under reduced pressure, (5) It 4.5
5 g (yield 95.15K) is obtained.

(5):II−NMR(CDCI:+)  5.30(
IH.、dt,J− 18and7、5 Hz,−CH
冨OF−) 〜 NS  C9B+4F+028r+ [252.018
01 252.0157アルゴン気流下、−78℃でジ
イソプロピルアミy (d=0.894,0.43s+
1.6smol)のエーテル溶液(I0ml)に、n−
BuLi(I.4M ヘキサン溶液3.3ml)を加え
て, 20分間攪拌後、フェニルチオ酢酸エチルエステ
ル(830厘g,4.7+s層01)を加え15分間攪
拌し、次にヘキサメチルホスホリックトリアミド(HM
PA) (M曽.179.20,d−1.03, 3m
l)を加えて、5分間攪拌した後、(5)(Ig.3.
95mmol)を加え,室温まで徐々に温度を上げ、9
0分間攪拌する.反応液に食塩水を加え、エーテルで2
回抽出し、有機層を2回水洗し、MgSO4で乾燥後、
減圧下濃縮し残液をシリカゲルカラムクロマトグラフィ
ーにより精製(hexane:AcOEts5:1) 
l,、(6)を1、19.  (収率82z)得る。
(5): II-NMR (CDCI: +) 5.30 (
IH. , dt, J- 18 and 7, 5 Hz, -CH
TomiOF-) ~ NS C9B+4F+028r+ [252.018
01 252.0157 Diisopropylamine y (d=0.894, 0.43s+
n-
Add BuLi (3.3 ml of I.4M hexane solution) and stir for 20 minutes, then add phenylthioacetic acid ethyl ester (830 g, 4.7+s layer 01) and stir for 15 minutes, then add hexamethylphosphoric triamide. (HM
PA) (Mso.179.20, d-1.03, 3m
After adding (5) (Ig.3.1) and stirring for 5 minutes,
95 mmol) was added, and the temperature was gradually raised to room temperature.
Stir for 0 minutes. Add brine to the reaction solution and dilute with ether.
After extraction, the organic layer was washed twice with water and dried with MgSO4.
Concentrate under reduced pressure and purify the residual liquid by silica gel column chromatography (hexane: AcOEts 5:1)
l,, (6) as 1, 19. (yield: 82z).

上記(Ei)のチオエステル(I. 19g,3.23
1鳳ol)のア七トン溶液(30ml)にRaney 
Xi(W2)を少量づつ加え, 15分間撹拌する.反
応終了後,反応液をセライトろ過し,エーテルで2回抽
出して。
Thioester of the above (Ei) (I. 19g, 3.23
Raney in a solution (30 ml) of 1 ol)
Add Xi(W2) little by little and stir for 15 minutes. After the reaction was completed, the reaction solution was filtered through Celite and extracted twice with ether.

M g.s O sで乾燥後、減圧下濃縮する.残渣を
シリカゲルカラムクロマトグラフィーで精製(hexa
ne:AcOEt=5:1) I,、(7)を577m
g  (収率88.7%)得る。
Mg. After drying with sOs, concentrate under reduced pressure. The residue was purified by silica gel column chromatography (hexa
ne:AcOEt=5:1) I,, (7) 577m
g (yield 88.7%) is obtained.

(7):IH−NMR(CDC13)  5.12(I
H,dt,J− 21and7、5Hz, −CH畠C
F−) IR  :174O  c層−1 MS  (+2H+:+F+04[245.1188]
245.118B  。
(7): IH-NMR (CDC13) 5.12 (I
H, dt, J- 21and7, 5Hz, -CH Hatake C
F-) IR: 174O c layer-1 MS (+2H+:+F+04[245.1188]
245.118B.

(7) (2.4g,9.23層1o1)のエーテル溶
液(50ml)に、アルゴン気流下、−78℃で旧BA
L−Hのヘキサン溶液(0.7M,10.4ml)を加
え、1時間攪拌する.反応液に食塩水を加え、セライト
を用いてろ過し、エーテルで2回抽出して、有a層を2
回水洗し、MgSO4で乾燥後、減圧下濃縮する。
(7) In an ether solution (50 ml) of (2.4 g, 9.23 layers 1 o 1), old BA was added at -78°C under an argon stream.
Add a hexane solution of L-H (0.7M, 10.4ml) and stir for 1 hour. Brine was added to the reaction solution, filtered through Celite, extracted twice with ether, and the a-layer was extracted twice.
Wash twice with water, dry with MgSO4, and concentrate under reduced pressure.

残液をシリカゲルカラムクロマトグラフィーで精製(h
exane:AcOEt−2:1) L 、 (8)を
1.87Kg(収、率93.3%)得る。
The residual liquid was purified by silica gel column chromatography (h
Exane:AcOEt-2:1) L , (8) was obtained in an amount of 1.87 Kg (yield: 93.3%).

(8):IH−NMR((DC13)  5.12(I
8,dt,J−21and7、5Hz, −CH=CF
−) NS  C++H+9F+03[218.131712
18.129Bト ニ ド  (8) (8) (I.7g,7.8m腸o1)及びトリエチル
アミン(2.713g,20.0m厘0りの塩化メチレ
ン溶液に,アルゴン気流下,−23℃(四塩化炭素−ド
ライアイス浴)で塩化メタンスルホニル(MW114.
5 、 d−1、48,0.111ml,11.8s+
nol)を加え. 10分間攪拌する.反応液に食塩水
を加え、エーテルで抽出する.エーテル抽出液を2回水
洗、乾燥( MgSOa )後,減圧下濃縮し、(9)
を2.0g (収率80%)得る。
(8): IH-NMR ((DC13) 5.12(I
8, dt, J-21 and 7, 5Hz, -CH=CF
-) NS C++H+9F+03 [218.131712
18.129B tonido (8) (8) (1.7 g, 7.8 m intestine) and triethylamine (2.713 g, 20.0 m in methylene chloride solution at -23°C under an argon atmosphere) Methanesulfonyl chloride (MW 114.
5, d-1, 48, 0.111ml, 11.8s+
add nol). Stir for 10 minutes. Add brine to the reaction solution and extract with ether. The ether extract was washed twice with water, dried (MgSOa), and concentrated under reduced pressure to obtain (9)
2.0 g (yield 80%) is obtained.

(9):IH−NNR(CDC13)  4.99(I
H,dt,J=7.5and21Hz,−CH=CF−
) Is  C目H+sFOsS(M・−〇〇3)[2B1
.0857]281.0842アルゴン気流下. KC
N(I2.3g,4111層鳳01)のIINF溶液(
50ml)に、18−crovn−8を触媒量加えた後
、(9) (I.8g,8.0mmol)  を加え、
50℃で5時間攪拌する.反応液に食塩水を加えエーテ
ルで2回抽出し、有機層を2回水洗. MgSO4で乾
燥後、減圧下濃縮する。残渣をシリカゲルカラムクロマ
トグラフ 4 − テ(hexane:AcOEt=5
:1)で精製し、 (io)を1.2g (収率88%
)を得る。
(9): IH-NNR (CDC13) 4.99 (I
H, dt, J=7.5and21Hz, -CH=CF-
) Is Cth H + sFOsS (M・-〇〇3) [2B1
.. 0857] 281.0842 Under argon flow. K.C.
IINF solution of N (I2.3g, 4111 layers 01) (
After adding a catalytic amount of 18-crovn-8 to (50 ml), (9) (I.8 g, 8.0 mmol) was added,
Stir at 50°C for 5 hours. Add brine to the reaction solution, extract twice with ether, and wash the organic layer twice with water. After drying with MgSO4, it is concentrated under reduced pressure. The residue was purified by silica gel column chromatography using 4-hexane (AcOEt=5).
:1) to obtain 1.2g of (io) (yield 88%)
).

(I0):  l)l−NMR(GDIII:13) 
 5.21(IH,dt、J=21and7.5Hz、
−CH=CF−) NaOH(28mmol)の820 (2+112) 
とMaOH(3ml)の溶液に(I0)(800mg、
2.64mmol)を加え、24時間加熱還流させたの
ち、室温に戻す9反応液をエーテル(I0ml)で希釈
し、0℃でlO%HGIを加え、酸性とする8反応液を
エーテルで2回抽出し、有機層を2回水洗、NgSOs
で乾燥後、減圧下濃縮する。残渣を塩化メチレン(5層
りで希釈し、0℃でCH2N2のエーテル溶液をN2が
発泡しなくなるまで加え、さらに5分間攪拌した後反応
液を儂縮し、残渣をシリカゲルカラムクロマトグラフ(
−により精製(hexane :AcOEtg2 : 
1) L、(I1)を550mg  (収率80%)を
得た。
(I0): l)l-NMR (GDIII:13)
5.21 (IH, dt, J=21and7.5Hz,
-CH=CF-) 820 (2+112) of NaOH (28 mmol)
(I0) (800 mg,
2.64 mmol) was added, heated under reflux for 24 hours, and then returned to room temperature. 9. The reaction solution was diluted with ether (I0 ml), and 10% HGI was added at 0°C to make it acidic. 8. The reaction solution was diluted with ether twice. Extract and wash the organic layer twice with water, NgSOs
After drying, concentrate under reduced pressure. The residue was diluted with methylene chloride (5 layers), and an ether solution of CH2N2 was added at 0°C until N2 stopped bubbling. After stirring for an additional 5 minutes, the reaction solution was evaporated, and the residue was subjected to silica gel column chromatography (
- Purified by (hexane: AcOEtg2:
1) 550 mg (yield 80%) of L, (I1) was obtained.

(I1): ’H−NMR(GDCI3)  5.05
(IH,dt、J=2!and7.5Hz、 −CH=
CF−) IR:  1740  cm−1 MS  Cl2H18F104  [245,1188
1245,1185(I1)(3EfOmg、1.38
mmol)のMeOH溶液(7,5m1)に濃塩酸(0
,5m1)をhaえ、室温で1時間攪拌後、エーテル(
I0ml)で希訳し、NaHCO3を加え中和した後、
セライトを用いてろ過、ろ液をNgSO,で乾燥後、減
圧下濃縮し、(I2)を207鵬g(収率882)得る
(I1): 'H-NMR (GDCI3) 5.05
(IH, dt, J=2!and7.5Hz, -CH=
CF-) IR: 1740 cm-1 MS Cl2H18F104 [245,1188
1245,1185 (I1) (3EfOmg, 1.38
concentrated hydrochloric acid (0 mmol) in MeOH solution (7.5 ml)
, 5ml) was stirred at room temperature for 1 hour, and then ether (
After diluting with I0ml) and neutralizing by adding NaHCO3,
Filter using Celite, dry the filtrate with NgSO, and concentrate under reduced pressure to obtain 207 g (yield: 882) of (I2).

(!2) : IH−MNR(CDCh)  δ:5.
07(IH,dt、J=21and7.5Hz)(I2
)(I52mg、0.Hmmoi)の塩化メチレン溶液
(5,5鳳l)に−78℃で、四酢酸鉛(M曽、443
.37480mg、1.03s諺al )を加え、10
分間攪拌し、エーテル(I0ml)で希釈し、セライト
を用いてろ過し、ろ液に水を加えエーテルで2回抽出し
、NaHCO3水で洗い、MgSO4で乾燥後、減圧下
濃縮し、(I3)ヲ78mg (収率58z)得る。
(!2): IH-MNR (CDCh) δ:5.
07 (IH, dt, J=21and7.5Hz) (I2
) (I 52 mg, 0.
.. Add 37480mg, 1.03s proverb), 10
Stir for 1 minute, dilute with ether (I0 ml), filter through Celite, add water to the filtrate, extract twice with ether, wash with NaHCO3 water, dry over MgSO4, and concentrate under reduced pressure. (I3) 78 mg (yield 58z) was obtained.

(I3):  IH−MNR(CDCh)  δ:5.
30(IH,dt、J=21and7.5Hz)。
(I3): IH-MNR(CDCh) δ:5.
30 (IH, dt, J=21 and 7.5Hz).

9.78(IH,−CHo) 参考例 5−フルオロアラキドン酸メチルの合成[(3z、8z
)−ドデカジエン−1−イル] トリフェニルホスホニ
ウム ヨーシト(220mg、0.5mmol)の無水
T)IF溶液(51)にn−ブチルリチウム(I゜4M
へキサン溶液、0.3m+! 、0.42txm□1)
を−78℃で滴下し、15分間攪拌後へキサメチルリン
酸トリアミド(HMPA)(0,81m1)を加えて5
分間攪拌する。この反応液に(I3)(78mg、0.
41mmol)の丁HF溶液(31)を加え30分間攪
拌後、室温まで昇温する0反応液を飽和炭酸水素ナトリ
ウム水溶液中にあけ、エーテルで2回抽出し、水洗(2
回)、乾燥(無水硫酸マグネシウム)後、減圧下濃縮す
る。残渣をシリカゲルカラムクロマドグ・ラフ・イーで
精製しくヘキサン:酢酸エチル−20:1 ) 。
9.78 (IH, -CHO) Reference Example 5 - Synthesis of methyl fluoroarachidonate [(3z, 8z
)-dodecadien-1-yl] n-butyllithium (I°4M
Hexane solution, 0.3m+! , 0.42txm□1)
was added dropwise at -78°C, and after stirring for 15 minutes, hexamethylphosphoric acid triamide (HMPA) (0.81ml) was added.
Stir for a minute. To this reaction solution (I3) (78 mg, 0.
After stirring for 30 minutes, the reaction mixture was heated to room temperature and poured into a saturated aqueous sodium bicarbonate solution, extracted twice with ether, washed with water (2
After drying (anhydrous magnesium sulfate), concentrate under reduced pressure. The residue was purified using a silica gel column chromatograph (hexane:ethyl acetate (20:1)).

目的物を33mg (収率24%)得た:IH−NMR
(CDCh)  、 δ2.30(2H,dt、J−7
,2,23Hz)。
33 mg (yield 24%) of the target product was obtained: IH-NMR
(CDCh), δ2.30 (2H, dt, J-7
,2,23Hz).

5.05(II(、dt、J−21,4,8Hz)  
;I9F−NMR(CDCh)  。
5.05 (II (, dt, J-21, 4, 8Hz)
; I9F-NMR (CDCh).

40.59(dt、 J−22,8Hz) ;MS(m
/e) 、338(N◆)。
40.59 (dt, J-22,8Hz); MS (m
/e), 338 (N◆).

Claims (1)

【特許請求の範囲】 1、下記式( I )で表わされるビニルフルオリド誘導
体 ▲数式、化学式、表等があります▼………………( I
) ただしA:▲数式、化学式、表等があります▼、▲数式
、化学式、表等があります▼、あるいは▲数式、化学式
、表等があります▼(ただし、R^1はアルキレン基) B;−(CH_2)−_mCOOR^2、あるいは−(
CH_2)−_nXただし、R^2は1価アルコールの
残基、あるいは水素原子。 Xは水酸基、ハロゲン原子、あるいはニトリル基 mは0〜5の整数 nは1〜5の整数 2、下記式(II)で表されるアルデヒド類と下記式(I
II)で表されるウイッチヒ試薬を反応させ、必要に応じ
てさらに還元、ハロゲン化、および/または増炭反応を
行なうことを特徴とする下記式( I )で表されるビニ
ルフルオリド誘導体の製造法。 ▲数式、化学式、表等があります▼(II) ▲数式、化学式、表等があります▼(III) ただし、R^4:アルキル基、アリール基、あるいはア
ルアルキル基 B:−(CH_2)−_mCOOR^2、あるいは−(
CH_2)−_nXR^2は1価アルコールの残基、あ
るいは水素原子、 Xは水酸基、ハロゲン原子、あるいはニトリル基 mは0〜5の整数 nは1〜5の整数
[Claims] 1. Vinyl fluoride derivative represented by the following formula (I) ▲There are numerical formulas, chemical formulas, tables, etc.▼……………………(I
) However, A: ▲There are mathematical formulas, chemical formulas, tables, etc.▼, ▲There are mathematical formulas, chemical formulas, tables, etc.▼, or ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (However, R^1 is an alkylene group) B;- (CH_2)-_mCOOR^2 or -(
CH_2)-_nX However, R^2 is a monohydric alcohol residue or a hydrogen atom. X is a hydroxyl group, a halogen atom, or a nitrile group m is an integer from 0 to 5 n is an integer 2 from 1 to 5;
Production of a vinyl fluoride derivative represented by the following formula (I), which is characterized by reacting the Witschig reagent represented by II) and further performing reduction, halogenation, and/or carbonization reactions as necessary. Law. ▲There are mathematical formulas, chemical formulas, tables, etc.▼(II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(III) However, R^4: Alkyl group, aryl group, or aralkyl group B: -(CH_2)-_mCOOR ^2, or -(
CH_2)-_nXR^2 is a residue of a monohydric alcohol or a hydrogen atom,
JP11137885A 1985-05-25 1985-05-25 Vinyl fluoride derivative and production thereof Pending JPS61271234A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11137885A JPS61271234A (en) 1985-05-25 1985-05-25 Vinyl fluoride derivative and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11137885A JPS61271234A (en) 1985-05-25 1985-05-25 Vinyl fluoride derivative and production thereof

Publications (1)

Publication Number Publication Date
JPS61271234A true JPS61271234A (en) 1986-12-01

Family

ID=14559666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11137885A Pending JPS61271234A (en) 1985-05-25 1985-05-25 Vinyl fluoride derivative and production thereof

Country Status (1)

Country Link
JP (1) JPS61271234A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315166A2 (en) * 1987-11-04 1989-05-10 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0315166A2 (en) * 1987-11-04 1989-05-10 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
JPH01151535A (en) * 1987-11-04 1989-06-14 Merrell Dow Pharmaceut Inc Fluorinated arachidonic acid derivative

Similar Documents

Publication Publication Date Title
Linderman et al. Oxidation of fluoroalkyl-substituted carbinols by the Dess-Martin reagent
US4870199A (en) Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
Duan et al. Synthesis of trifluoromethyl aryl derivatives via difluorocarbene precursors and nitro-substituted aryl chlorides
JPS61129178A (en) Hmg-coa reductase inhibitor and manufacture of intermediate compound therefor
JPS61271234A (en) Vinyl fluoride derivative and production thereof
US4325877A (en) Production of intermediates for enzyme inhibitors
JP2622887B2 (en) Isoxazole derivative and method for producing the same
JPS606942B2 (en) Acid production method for 1-(β-aryl)ethyl-1H-imidazole ether and its acid addition salt
JPH0739368B2 (en) 20,20,20-Trifluoroarachidonic acid derivative and method for producing the same
JP2917552B2 (en) Method for producing α-methylenecyclopentanone derivative
FR2473507A1 (en) PROCESS FOR THE PRODUCTION OF ARYLPROPIONIC ACIDS
JP5170987B2 (en) Novel fluorine-containing unsaturated silyl ether compound and method for producing fluorine-containing unsaturated alcohol derivative using the compound as an intermediate
JPS61271246A (en) 5-fluoroarachidonic acid derivative and production thereof
US4235779A (en) Bicyclic lactones
CH605584A5 (en) Halo-cyclopropyl aryloxy alkanoic acids and esters
JPS61122240A (en) Manufacture of halogenated 3,3_dimethyl_5_ hexen_2_one
US5354874A (en) Substituted-acyclic terpene compound
JPH053859B2 (en)
JP3596120B2 (en) Method for producing lower alkyl ester of α-cyano-tert-butylacetic acid
JPS6141330B2 (en)
JPS58194837A (en) Preparation of diphenylmethane derivative
JPH04305548A (en) Halogeno allyl alcohol derivative
JPS6287590A (en) Isocarbacycline derivative and its preparation
JPS6022704B2 (en) Prostaglandin-like compound intermediate and method for producing the same
JPS6036415B2 (en) Method for producing 2-pentene derivatives